Dosing Schedule Details Induction Phase: Patients in both the treatment and control arms receive loading doses of aflibercept at Day 1, Week 4, and Week 8.
DURAVYU Administration: The initial intravitreal dose of DURAVYU is administered at Month 2 (Week 8) of the trial.
Redosing Interval: Subsequent doses of DURAVYU are administered every six months throughout the duration of the study.
Control Arm: The comparison group receives on-label aflibercept at intervals following the initial loading doses. ---------------------------- So if I understand this correctly . Both start out with Eylea for first 8 wks ....then the EYPT drug is dosed only every 6 mths from then on vs the Eylea drug being doses on schedule as per label.
Market Data 
Markets 
AI
